Macerich Co (MAC) is not a strong buy for a beginner, long-term investor at this moment. The technical indicators are mixed, options sentiment leans bearish, and the company's financial performance has been weak. While there are some positive analyst upgrades, the overall sentiment is cautious due to the company's over-levered balance sheet and declining fundamentals. Given the user's impatience and unwillingness to wait for optimal entry points, holding off on this investment is recommended.
The MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 45.162, showing no clear signal. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below the pivot level of 20.157, with key support at 19.53. Overall, the technical indicators are mixed.

KeyBanc's upgrade to Overweight with a $25 price target and optimism about the company's 'Path Forward Plan' execution. Some analysts see potential for improving net operating income growth and funds from operations in 2026.
Weak financial performance in Q4 2025 with significant declines in revenue (-4.37% YoY), net income (-91.04% YoY), and EPS (-92.13% YoY). Over-levered balance sheet and cautious sentiment on mall REITs due to higher interest rates. Options sentiment is bearish, and there is no recent news or significant insider/hedge fund activity.
In Q4 2025, revenue dropped by 4.37% YoY to $261.7M. Net income plummeted by 91.04% YoY to -$18.95M, and EPS fell 92.13% YoY to -$0.07. Gross margin decreased by 10.72% to 22.57%. The financial performance indicates significant challenges in profitability and growth.
Analyst sentiment is mixed. KeyBanc upgraded the stock to Overweight with a $25 price target, citing progress on the 'Path Forward Plan.' However, Goldman Sachs maintains a Sell rating with a $17 price target. Other analysts have raised price targets but remain cautious about the company's over-levered balance sheet and challenges in the mall REIT sector.